… effect in the pharmaceutical sector. This could be partly explained by the fact that companies
… higher interest expenses offset the positive effects of financial returns, which is also partly …

… effect in the pharmaceutical sector. This could be partly explained by the fact that companies
… higher interest expenses offset the positive effects of financial returns, which is also partly …

… and commercial sectors in the national economy has noticeably intensified, as a result of
the COVID-19 pandemic. The main objective of this study was to gain a better insight into the …

… of innovation would be dramatic, but the adverse effects would not be noticeable to consumers …
-the-board profit reduction for new drugs would not have a noticeable impact on new drug …

… , firm profitability and financial factors, in the post crisis period, using a sample of Greek …
pharmaceuticals industry, given that it is a job creator and essential for the society and economy …

… that profit rates of return on pharmaceutical industry R&D investments tend to exceed risk-…
pharmaceutical industry R&D is best described by a virtuous rent-seeking model. That is, as …

… This profitable sector has the least possible risks associated with comparison to other …
on stock price is necessary for the purpose of portfolio management and risk management. …

… If we look at the results of all the pharmaceutical companies studied, the gross profit on
sales was on average half of the sales achieved in almost all years, through the segment of …

… as the pharmaceutical business operation in emerging economies … profit growth, which may
impact and improve the financial … pharmaceutical companies, and sometimes, this new profit …

… profitability and sales growth are significant and negative across all model specifications.
These results suggests that the more profitable the firm and the higher its sales, the less risk …